James E. Wagner Cultivation Corporation Licenses its Proprietary GrowthSTORM™ System to Affiliate Cannabis Producer

James E. Wagner Cultivation Corporation (TSX VENTURE: JWCA), is pleased to announce it has entered into a non-binding letter of intent to licence its GrowthSTORMTM system & SOP’s to Wellness Farms Inc. for use at its proposed cannabis cultivation premises.

Benchmark Initiates Coverage On Canopy Growth Corp With $100 Price Target

Benchmark starts its coverage on Canopy Growth Corp WEED.TO with a "buy" rating citing the Canadian marijuana producer's exposure to meaningful demand drivers

** U.S.-listed shares of Canopy CGC.N up 3 pct at $54.10 before the bell

** Sets a C$100 PT, easily the highest on the Street, implying a 47 pct upside to WEED's last close

3 Canadian Licensed Producers Making Headlines

Canadian cannabis producers recorded mixed movements after 11 of them signed supply agreements with the province of Alberta and we expect to see more deals like this materialize in the near future.

With Canada’s recreational cannabis market set to open on October 17th, provinces have to move quickly to be ready and we are excited by this opportunity. Today, we have highlighted three companies focused on this opportunity that investors need to be aware of.

3 Canadian Cannabis Leaders You Need To Be Watching

Although the cannabis sector has been under pressure a little pressure recently, there has been some significant recent announcements that caught our attention.

During the last month, several cannabis companies have announced some major developments and opportunities. We are monitoring the recent developments and have highlighted 3 recent announcements that investors need to be aware of.

Choom Surges on Strategic Investment from Aurora Cannabis

Medical Cannabis Leadership from Canopy Growth and Subsidiary Spectrum Cannabis

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to provide the following updates on its medical cannabis program and to re-affirm its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it.

Canopy Growth and Molecular Science Corp. Announce Collaboration to Advance Cannabis Testing Across Canada

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has entered into a collaboration agreement with Canadian laboratory services company Molecular Science Corp. ("MSC") to advance cannabis testing, support product knowledge, and enhance safety awareness, all part of the responsible development of the Canadian cannabis industry.